Clinical Trial Update: Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial compares vinorelbine–ifosfamide with gefitinib in EGFR gene mutation–negative non-small cell lung cancer; the status of the trial is currently u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)
• IFOSFAMIDE (IFOSFAMIDE)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Non-small Cell Lung Cancer, Effects of Chemotherapy | Phase 2 | Status: UNKNOWN